Since its foundation in 2008, Ampio Pharmaceuticals (NYSE: AMPE) has been focused on delivering a drug that treats inflammation caused by a
Ampio Pharmaceuticals Inc.
-(AMPE)
OTCM:AMPE
Ampio Pharmaceuticals Inc (AMPE) Q3 2020 Earnings Call Transcript
Ampio Pharmaceuticals Inc (NYSE American: AMPE) Q3 2020 Earnings Call dated Nov. 05, 2020 Corporate participants: Joseph Hassett -- Investor Relations Michael Macaluso -- Founder, Chairman